Doximity IncDOCS
Price$28.50Intrinsic value$33.0416% above price

Qualitative Analysis

Business overview

Business Overview

Doximity, Inc. operates the leading digital platform for U.S. medical professionals, serving as a secure professional network, communication hub, and workflow tool. The platform's membership includes over 80% of U.S. physicians across all specialties and practice areas. Doximity provides its members with free access to tools designed to coordinate patient care, conduct virtual patient visits, collaborate with colleagues, and manage their careers. The company monetizes its platform primarily by offering commercial solutions to pharmaceutical manufacturers and healthcare systems, who pay to reach and engage its highly concentrated physician audience.

Research as of 19 Jun 2026

Strategic Initiatives

Growth programs, investments, and their expected impact

AI-assisted
AI Investment Year (Fiscal 2027)Innovation

Accelerating spending on artificial intelligence to build and scale Doximity's clinical AI suite, including its ambient notetaking tool Scribe and clinical AI assistant/medical search engine Ask (formerly DoxGPT). This includes increased R&D, compute, and brand marketing spend.

Expected impact: Aims to establish Doximity as the leading AI platform for doctors, driving long-term physician engagement and unlocking a multibillion-dollar new TAM in AI search on top of existing pharma marketing budgets.

Sign in / Sign up to read more
InvestmentIncreased R&D and compute costs, which are expected to compress adjusted EBITDA margins from 55% in fiscal 2026 to approximately 49% in fiscal 2027.
TimelineFiscal Year 2027 (began April 1, 2026)
Clinical AI Integration with Value-Based CareExpansion

Integrating Doximity's HIPAA-compliant Clinical AI Suite (Scribe and Ask) directly into Aledade Assist, the electronic health record (EHR) overlay of value-based care enablement company Aledade.

Expected impact: Expands Doximity's reach to more primary care physicians across Aledade's national network of over 3,000 primary care organizations, embedding Doximity's workflow tools into daily clinical care for practices caring for over 3 million patients.

Sign in / Sign up to read more
InvestmentR&D integration and deployment resources.
TimelineAnnounced May 13, 2026; rollout ongoing.
In-Workflow E-Prescribing CapabilitiesInnovation

Partnering with Photon Health to add in-workflow e-prescribing capabilities directly to the Doximity platform.

Expected impact: Deepens physician workflow integration, making the platform a more essential daily utility for clinicians and driving higher overall platform engagement.

Sign in / Sign up to read more
InvestmentProduct development and integration resources.
TimelineBeta rollout completed with over 1,000 prescribers; scaling ongoing.
Sources: 1

Mergers, Acquisitions & Partnerships

Recent deals and strategic collaborations

AI-assisted

Recent Acquisitions

Pathway Medical Inc.$63M
Announced 7 Aug 2025

To acquire Pathway's structured medical datasets and evidence-based clinical knowledge platform, strengthening Doximity's clinical AI search capabilities and providing a sturdier scientific backbone for its AI tools.

Financial impact: The transaction closed for $26 million in cash and up to $37 million in additional equity grants. The acquisition and subsequent performance-based grants for the AI team are the primary drivers of increased stock-based compensation in fiscal 2027.

Sign in / Sign up to read more

Strategic Partnerships

Aledade, Inc.Clinical AI Integration & Distribution Partnership

High. Aligns Doximity's AI Scribe and Ask assistant with a large, national network of independent primary care practices operating in value-based care environments, driving deeper clinician usage and EHR integration.

Terms: Financial terms of the integration agreement were not disclosed.

Sign in / Sign up to read more
Photon HealthProduct Integration & Workflow Partnership

Medium. Integrates e-prescribing capabilities directly into Doximity's workflow, enhancing the platform's utility as a daily clinical tool for prescribers.

Terms: Financial terms of the partnership were not disclosed.

Sign in / Sign up to read more
Sources: 1
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.